Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Vaccines
•
Allergy & Immunology
How long do you counsel patients to wait after rituximab therapy before getting live vaccines?
Related Questions
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Why are influenza and COVID vaccines still recommended for patients on immunoglobulin replacement therapy?
Do patients with a PEG allergy have a contraindication to receiving mRNA vaccines?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How exhaustive (especially considering cost) should an immunological workup be for patients with extensive, recurrent, or deep seated Staph aureus infections without obvious immunocompromise (e.g. cancer, diabetes, steroids) or recurrent breaks in skin integrity?
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?
Do you utilize AIT for atopic dermatitis if there is no AR present?
Do you avoid use of inhalers with milk protein in patients with a milk allergy?
Do you alter therapy for GLILD from antimetabolite/rituximab to monotherapy if the biopsy is predominantly T or B cells?
